Department of Neurosurgery, Strasbourg University Hospital, Strasbourg, France.
Department of Neurosurgery, Strasbourg University Hospital, Strasbourg, France.
Neurochirurgie. 2021 Apr;67(2):99-103. doi: 10.1016/j.neuchi.2021.01.009. Epub 2021 Jan 22.
The objective of this study was to relate the neurosurgical activity during a time of sanitary crisis such as experienced during the SARS-CoV-2 pandemic.
A monocentric retrospective analysis was made based on a prospectively gathered cohort of all patients requiring neurosurgical care between March 15th and May 12th, 2020. Local impact of SARS-CoV-2 was analysed regarding number of patients admitted in ICU.
One hundred and sixty patients could benefit from neurosurgical care with a wide-ranging profile of clinical and surgical activities performed during the study that seemed similar to last year profile activity. Surgical indications were restricted to non-deferrable surgeries, leading to a drop in operative volume of 50%. Only 1.3% of patients required transfer to other units due to the impossibility of providing gold standard neurosurgical care in our centre.
Despite the challenges represented by the SARS-CoV-2 pandemic, it was proven possible to ensure the routine neurosurgical continuity and provide high standards of neurosurgical care without compromising patients' access to the required treatments.
本研究旨在探讨在 SARS-CoV-2 大流行等卫生危机期间神经外科活动的相关情况。
基于 2020 年 3 月 15 日至 5 月 12 日期间所有需要神经外科治疗的患者前瞻性收集的队列，进行单中心回顾性分析。分析 SARS-CoV-2 对 ICU 收治患者数量的局部影响。
共有 160 名患者接受了神经外科治疗，其临床和手术活动范围广泛，与去年的活动情况相似。手术指征仅限于不可延迟的手术，导致手术量下降了 50%。由于无法在我们中心提供标准的神经外科治疗，只有 1.3%的患者需要转至其他科室。
尽管 SARS-CoV-2 大流行带来了挑战，但仍有可能确保常规神经外科的连续性，并提供高标准的神经外科治疗，而不会影响患者获得所需治疗的机会。
